indirubin-3'-monoxime has been researched along with Idiopathic Parkinson Disease in 2 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doggrell, SA | 1 |
| Castelo-Branco, G | 1 |
| Rawal, N | 1 |
| Arenas, E | 1 |
2 other studies available for indirubin-3'-monoxime and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2.
Topics: Animals; Antiparkinson Agents; Cell Culture Techniques; Cell Death; Corpus Striatum; Genetic Vectors | 2011 |
GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
Topics: Animals; Benzazepines; beta Catenin; Brain; Cell Differentiation; Cell Proliferation; Cell Survival; | 2004 |